Djibouti vs Madagascar: Share of pregnant women with HIV that receive antiretroviral therapy
Djibouti
38.0%
in 2024
Madagascar
30.0%
in 2024
Djibouti rank
74th
Madagascar rank
77th
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Djibouti
- Madagascar
How they compare
Djibouti currently reports 38.0% against 30.0% in Madagascar, a difference of 8.0%.
That makes Djibouti's figure about 1.3 times Madagascar's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Madagascar ahead.
Djibouti ranks 74th and Madagascar ranks 77th of 84 countries.
Djibouti has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.4% | 1.1% | 5.3% | Djibouti |
| 2010s | 28.2% | 7.8% | 20.4% | Djibouti |
| 2020s | 34.0% | 21.4% | 12.6% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Djibouti or Madagascar?
- Djibouti, at 38.0% against 30.0% in Madagascar as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Djibouti and Madagascar?
- 8.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Madagascar?
- 25 years are reported by both, from 2000 to 2024.
- How do Djibouti and Madagascar rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Djibouti ranks 74th and Madagascar ranks 77th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.